Loading...
Using 2(nd) generation tyrosine kinase inhibitors in frontline management of chronic phase chronic myeloid leukemia
Choices in medicine come with responsibility. With several TKI's (Tyrosine kinase inhibitors) available for front-line management of CML (Chronic Myeloid Leukemia), an astute clinician has to personalise, rationalise and take a pragmatic approach towards selection of the best drug for the ‘pati...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Medknow Publications & Media Pvt Ltd
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3961879/ https://ncbi.nlm.nih.gov/pubmed/24665456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2278-330X.126566 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|